Investment Opportunities in Meditech
•
0 likes•50 views
In the wake of the pandemic, medical innovations are causing more excitement than ever before. Not only do these innovations improve lives, but the enterprises behind them are likely to be extremely profitable too. Investment Owl is helping to raise funds for these concerns.
Report
Share
Report
Share
Download to read offline
Recommended
Spain’s Top 10 Companies Booming in Healthcare Sector 2022.pdf
Insights Care has brought you a brand-new edition, ‘Spain’s Top 10 Companies Booming in Healthcare Sector 2022.'
Lif follow on support programme - chu duc hoang
Isis Innovation analysed the project entitled “Zinmed Vietnam JSC” originating from LIF Fellow, Chu Duc Hoang from Zinmed, Vietnam in terms of its long, medium and short-term commercialisation potential. The invention is a
treatment management application for diabetics. It provides news and automatic healthcare tracking tools via a smartphone and wearable device and includes appointment management service linked to doctors, clinics and hospitals
Pharmaceutical Fraud: Health 2.0 Conference Highlights Scams
This presentation by Health 2.0 Conference talks about pharmaceutical fraud and what are some of the most common spam perpetrated by scammers. This presentation also highlights how AI can help mitigate the effects of fraud better than any traditional method.
2012 EY Biotech Report
The document discusses the need for a new paradigm for funding and conducting biotech research and development (R&D) given constraints in the current financing environment. It proposes a model called Holistic Open Learning Networks (HOLNets) that would bring together diverse participants like healthcare providers, patient groups, data analytics firms, and social media networks. HOLNets could fundamentally change R&D by encouraging data sharing, allowing researchers to learn from each other in real time, and taking advantage of the shift in healthcare to outcomes-focused and data-driven models.
Top 10 biotech venture fund
According to the website Investopedia, venture capital is a kind of private equity funding that is given by investors to new enterprises and small businesses that the investors feel have the potential for long-term development. In general, it is derived from wealthy investors, investment banks, and many other financial entities.
Reinvigorating Early Stage Medtech Innovation
Many startup companies are struggling to make it out of the “valley of death” – the period between the initial investment and creation of a commercially-viable product.
Financial pressures that stem from health care reform, the transition to value-based care, tougher insurance coverage, and increased regulatory requirements are causing some corporate and venture capital investors to step back from making investments in early-stage, as yet unproven, medtech innovation and technologies.
Consequently, investment and startup activity in medtech has been declining, putting future medtech innovation at risk.
The 10 companies booming in healthcare sector small
Development is a continuous process in any sector. It brings in more comfort, more precision, and more enhanced way of living.Acknowledging the remarkable contribution of the leading companies in the care sector, we bring to you the special issue of “The 10 Companies Booming in Healthcare Sector”.
Taking The Pulse of Medtech innovation_Pitchbook, Dec, 2021
Report by Pitchbook (a Morningstar company), December, 2021- Taking the Pulse of Medtech Innovation. Medtech versus biotech: A capital investment comparison of the life sciences subsectors.
The red-hot life sciences industry has seen incredible growth in the last decade as the biomedical revolution of the early 21st century has gained traction. Key discoveries, ranging from the development of recombinant protein production to bioprosthetic implants to genome engineering, have propelled capital investment from VC investors to the tune of$20 billion annually for the past three years, with over $44 billion already deployed to life sciences companies in 2021 alone. Given large-cap multinational companies’ aversion to investing financial and human capital into high-risk early-stage research & development (R&D) projects, innovation within life sciences has fallen upon startups and venture-backed companies.
Recommended
Spain’s Top 10 Companies Booming in Healthcare Sector 2022.pdf
Insights Care has brought you a brand-new edition, ‘Spain’s Top 10 Companies Booming in Healthcare Sector 2022.'
Lif follow on support programme - chu duc hoang
Isis Innovation analysed the project entitled “Zinmed Vietnam JSC” originating from LIF Fellow, Chu Duc Hoang from Zinmed, Vietnam in terms of its long, medium and short-term commercialisation potential. The invention is a
treatment management application for diabetics. It provides news and automatic healthcare tracking tools via a smartphone and wearable device and includes appointment management service linked to doctors, clinics and hospitals
Pharmaceutical Fraud: Health 2.0 Conference Highlights Scams
This presentation by Health 2.0 Conference talks about pharmaceutical fraud and what are some of the most common spam perpetrated by scammers. This presentation also highlights how AI can help mitigate the effects of fraud better than any traditional method.
2012 EY Biotech Report
The document discusses the need for a new paradigm for funding and conducting biotech research and development (R&D) given constraints in the current financing environment. It proposes a model called Holistic Open Learning Networks (HOLNets) that would bring together diverse participants like healthcare providers, patient groups, data analytics firms, and social media networks. HOLNets could fundamentally change R&D by encouraging data sharing, allowing researchers to learn from each other in real time, and taking advantage of the shift in healthcare to outcomes-focused and data-driven models.
Top 10 biotech venture fund
According to the website Investopedia, venture capital is a kind of private equity funding that is given by investors to new enterprises and small businesses that the investors feel have the potential for long-term development. In general, it is derived from wealthy investors, investment banks, and many other financial entities.
Reinvigorating Early Stage Medtech Innovation
Many startup companies are struggling to make it out of the “valley of death” – the period between the initial investment and creation of a commercially-viable product.
Financial pressures that stem from health care reform, the transition to value-based care, tougher insurance coverage, and increased regulatory requirements are causing some corporate and venture capital investors to step back from making investments in early-stage, as yet unproven, medtech innovation and technologies.
Consequently, investment and startup activity in medtech has been declining, putting future medtech innovation at risk.
The 10 companies booming in healthcare sector small
Development is a continuous process in any sector. It brings in more comfort, more precision, and more enhanced way of living.Acknowledging the remarkable contribution of the leading companies in the care sector, we bring to you the special issue of “The 10 Companies Booming in Healthcare Sector”.
Taking The Pulse of Medtech innovation_Pitchbook, Dec, 2021
Report by Pitchbook (a Morningstar company), December, 2021- Taking the Pulse of Medtech Innovation. Medtech versus biotech: A capital investment comparison of the life sciences subsectors.
The red-hot life sciences industry has seen incredible growth in the last decade as the biomedical revolution of the early 21st century has gained traction. Key discoveries, ranging from the development of recombinant protein production to bioprosthetic implants to genome engineering, have propelled capital investment from VC investors to the tune of$20 billion annually for the past three years, with over $44 billion already deployed to life sciences companies in 2021 alone. Given large-cap multinational companies’ aversion to investing financial and human capital into high-risk early-stage research & development (R&D) projects, innovation within life sciences has fallen upon startups and venture-backed companies.
10 Best Healthcare Companies in Australia & New Zealand 2023V3 1.pdf
This edition features 10 Best Community Health Management Companies 2022 across several sectors that are at the forefront of leading us into a digital future.
10 Best Healthcare Companies in Australia & New Zealand 2023V3 1.pdf
Insights Care's latest edition, 10 Best Healthcare
Companies in Australia & New Zealand 2023, introduces
you to the best industries in Australia and New Zealand that
are positioning themselves for success in an increasingly
competitive and dynamic industry by embracing innovation
controlling costs and focusing on the patient experience
MedTech Dealmakers, October 2015
This document summarizes recent trends in medical technology dealmaking and mergers and acquisitions. There have been several large "megamergers" in the medical technology space over the past year, including Medtronic's acquisition of Covidien for $49.9 billion. Other areas of focus for deals have been startups developing minimally invasive technologies, drug delivery devices, and digital health technologies. However, venture capital investment in medical devices overall remains lackluster compared to biotechnology.
10 most reliable cro’s to watch in 2021
We featured a few trustworthy CROs making a difference in the health space in our latest edition of Insights Care - 10 Most Reliable CROs to Watch in 2021.
Trailblazing The Immuno-Oncology Frontier Best Companies Of 2024.pdf
“Trailblazing The Immuno-Oncology Frontier Best Companies Of 2024” isn’t just a compilation of success stories; it’s a celebration of the triumph of the human spirit over adversity.
10 of the Best Healthcare Brands in 2020 | Insights Care
10 of the best healthcare brands in 2020 who are now part of this transformation, they have a deep understanding of how it functions & transformed.
Blog april2016 companycreation
The document profiles Sabin C. Carme, a transdisciplinary scientist with experience in industry R&D, innovation, and business. It discusses two company cases he has evaluated: PAPE, which involves a drug delivery system using local palladium activation for low toxicity therapy, and opportunities for building strategic advantages. It also includes an analysis of the company's competitive advantage, business model, market forces, strengths, weaknesses and opportunities for further assessment.
1- MarketingBefore putting the product into the market, the prod.docx
1- Marketing
Before putting the product into the market, the product goes through several stages. One of the most important stages is to determine the price of the product. After that, it will be studied by asking questions to customers and anticipate their requirements in terms of shape, colour phrases recorded on it. It can be applied using servery or interview the customer. Finally, the product needs to be promoting before it is been released, so electronic, and visual and audio can be used as advertising. However, in this experiment, we will focus only on the total cost of the product and then work on finding who develops the product….[9] [10].
1.1 Estimating of the total price.
For the antibiotic spray, it can be estimate the total price depend on the type of the material which were be used. Thus, the material in the table estimates the total price.
Material
Discerption
Brand/ manufacture
Price Ink VAT.
[1] Cefuroxime(as Cefuroxime sodium) 1.5 gram.
CEFUROXIME is a cephalosporin antibiotic. It is used to treat certain kinds of bacterial infections. It will not work for colds, flu, or other viral infections
£4.70
[2] Sterile Water (1000ml)
Single Bottle of Sterile Water (1000ml)
Baxter
£3.54
[3] 73.5 mg of sodium
Sodium Bicarbonate 2kg - Pharmaceutical Grade (Bicarb/Bicarbonate of Soda)
£6.49
[1] Metronidazole
Metronidazole 500mg/100ml infusion 100ml bags (A A H Pharmaceuticals Ltd)
£63.86
[4] Phosphatebuffer (pKa=7.2)
PBS405.1 Virtual PHOSPHATE BUFFERED SALINE pH 7.4 10X Liquid Concentrate, 1L
£22.75
[5] Brilliant Blue FCF
1 kilogram
£6-8
[6] 100ml Stainless Steel
Empty stainless bottle spray
£7-9
Total price
£118
2- Companies and industry
There are many companies interested to work on or collaborate for developing the antibiotic. Following, there are some of the companies, Charities and universities, which they work hardly to improve public health and more specifically in the development of antibiotics. Thus, the product will be a focuses for them and new idea that can be started to develop and prove its effectiveness. Then, it can be put in the market, which many people can take advantage of the ease and licences of the product.
2.1. GSK Company [13]
At GSK, they are at the forefront of researching new ways to tackle some of the world’s biggest healthcare challenges. So as antibiotic resistance grows, they are investing in new ways to fight infection.
Their approach is to make the most of their own expertise and experience, while at the same time forming complementary partnerships and alliances with others who bring different kinds of expertise. Their vision for the world, where everyone has access to the vaccines they need, depends on a steady supply of great ideas and brilliant science. They have much to offer and through collaboration, they can achieve so much more.
For example, more than 90% of the vaccines in their pipeline are being developed in partnership with others. They have a long track rec.
The 10 Companies Booming in Healthcare Sector
Acknowledging the remarkable contribution of the leading companies in the care sector, we bring to you the special issue of “The 10 Companies Booming in Healthcare Sector”. This edition portrays the inspiring stories of the listed pre-eminent organizations that are shaping the future of healthcare through innovation and dedication.
Case for emerging 9 sustaining oncology innovation
The document discusses the challenges facing major oncology innovator companies as their traditional cash cow drugs lose market share to biosimilars. It argues that innovators need to look beyond traditional Western markets and consider partnering with emerging markets like India to strengthen their healthcare systems and generate sustainable revenues. This could help build new cash cows to fund future innovation while improving access in populations with high cancer rates. The document outlines how an integrated approach with partners across government, non-profits and hospitals could work to mutually benefit patients, innovators and healthcare systems in emerging markets.
Canada's 10 Most Valuable Healthcare Solution Providers July 2021
Canada's 10 Most Valuable Healthcare Solution Providers July 2021 features some exceptional Canadian healthcare solution providers
Health-Tech: Endless opportunities & endless disruption
This document provides an overview of the health tech industry and key trends. It discusses how the industry has adopted digital technologies across areas like drug manufacturing, clinical trials, hospitals, and care services. The COVID-19 pandemic further increased adoption rates. The document analyzes funding and deal size data from the past 5 years to identify fast growing segments like telemedicine, anti-counterfeiting tech, and the rise of tech giants in healthcare investing. Post-pandemic, virtual consultations are expected to become more mainstream. The future of healthcare is predicted to rely more on technologies like artificial intelligence, digital tools, and data analytics.
The 10 most innovative healthcare companies in 2020
Alertgy was founded by Marc Rippen after his wife had a near-fatal low blood sugar attack. Rippen saw the need for an automated glucose monitor and alert system for diabetics that was non-invasive, inexpensive, and easy to use. As the president and founder of Alertgy, Rippen has over 30 years of experience in engineering and has commercialized many groundbreaking technologies. Alertgy provides the first non-invasive wearable continuous glucose monitor and alert system that can measure true blood glucose levels and send alerts when levels are too high or too low. This solution aims to improve compliance for diabetics and reduce hospital admissions related to blood sugar issues.
Practical guide on private funding for EU eHealth SMEs
The document discusses trends in digital health and investment in Europe compared to the US. Some key points:
1) Venture funding for digital health has grown rapidly in recent years on both sides of the Atlantic, with over $4 billion invested in the US in 2014 alone. However, investment in Europe still lags behind, though some large funding rounds have occurred.
2) Most digital health startups in Europe are still at the seed stage, but more are qualifying for Series A funding and beyond in recent years.
3) Factors holding back more investment in Europe include digital health initiatives still being in early stages of development and a fragmented healthcare system compared to the larger US market. Interviews with an investor
Johnson & Johnson Pharmaceutical Business Review
The document is an agenda for an investor presentation. It outlines the schedule for the day which includes presentations on the company's enterprise overview, pharmaceutical commercial and R&D strategies, and various therapeutic areas. It also includes notices about forward-looking statements and new molecular entities being discussed. The speakers and locations are listed next to each topic.
R & D PPT.pptx
The document outlines India's national policy on R&D and innovation in pharmaceuticals and medical devices. It discusses opportunities in areas like generics, APIs, vaccines, and biosimilars. The policy aims to incentivize investments, create an enabling ecosystem for innovation through strengthening academic-industry linkages, building infrastructure, and streamlining regulatory processes.
Healthcare Industry Analysis for Investors
The document discusses the healthcare sector as an investment opportunity. It notes that healthcare demand is defensive as people will still need it even during economic downturns. It identifies top industry players as drug companies, biotech companies, and medical device companies. Drug companies and device firms tend to have strong competitive advantages or "wide economic moats" due to high costs of research and development, patent protection, and other barriers to entry. However, the sector also carries risks such as long development timelines for drugs, regulatory hurdles, and loss of revenue when patents expire. The document provides an overview of factors to consider when evaluating investment opportunities in healthcare companies.
10 Most Innovative CRO’s To Watch In 2022.pdf
During the COVID-19 pandemic, if clinicians, healthcare service-providing staff, nurses, and doctors were battling at the forefront, then the Clinical Research Organizations (CROs) have been working hard
Asia HealthTech Investments by Julien de Salaberry (30 June 2015)
Kickstart Ventures' 2nd HealthTech Forum featured Julien de Salaberry, a globally-recognised expert on healthcare and technology.
Julien, the Chief Innovation Officer and Founder of The Propell Group (based in Singapore), talked about healthcare trends in Southeast Asia and how “frugal innovation" can be done in healthcare delivery.
And yeah, if you've got an interesting healthtech startup, message us at info@kickstart.ph. #startupPH
Powering the Future of Healthcare in Asia | Propell | Media Exploits
Presentation given at AStar ETPL Media Exploits conference on why healthtech will power the future of healthcare in Asia
Green Bonds Investment Opportunities
The current green bond investment opportunities offered by Investment Owl offer a return of between 8.25% and 12% per annum which is paid quarterly and takes the form of fully listed and tradeable ‘A’ rated income bonds. A minimum investment of $50,000 is required. This type of green investment proposition is becoming increasingly popular.
Introduction to the Ugandan Football Academy
Investment Owl’s investment opportunity for Ugandan football aims to
More Related Content
Similar to Investment Opportunities in Meditech
10 Best Healthcare Companies in Australia & New Zealand 2023V3 1.pdf
This edition features 10 Best Community Health Management Companies 2022 across several sectors that are at the forefront of leading us into a digital future.
10 Best Healthcare Companies in Australia & New Zealand 2023V3 1.pdf
Insights Care's latest edition, 10 Best Healthcare
Companies in Australia & New Zealand 2023, introduces
you to the best industries in Australia and New Zealand that
are positioning themselves for success in an increasingly
competitive and dynamic industry by embracing innovation
controlling costs and focusing on the patient experience
MedTech Dealmakers, October 2015
This document summarizes recent trends in medical technology dealmaking and mergers and acquisitions. There have been several large "megamergers" in the medical technology space over the past year, including Medtronic's acquisition of Covidien for $49.9 billion. Other areas of focus for deals have been startups developing minimally invasive technologies, drug delivery devices, and digital health technologies. However, venture capital investment in medical devices overall remains lackluster compared to biotechnology.
10 most reliable cro’s to watch in 2021
We featured a few trustworthy CROs making a difference in the health space in our latest edition of Insights Care - 10 Most Reliable CROs to Watch in 2021.
Trailblazing The Immuno-Oncology Frontier Best Companies Of 2024.pdf
“Trailblazing The Immuno-Oncology Frontier Best Companies Of 2024” isn’t just a compilation of success stories; it’s a celebration of the triumph of the human spirit over adversity.
10 of the Best Healthcare Brands in 2020 | Insights Care
10 of the best healthcare brands in 2020 who are now part of this transformation, they have a deep understanding of how it functions & transformed.
Blog april2016 companycreation
The document profiles Sabin C. Carme, a transdisciplinary scientist with experience in industry R&D, innovation, and business. It discusses two company cases he has evaluated: PAPE, which involves a drug delivery system using local palladium activation for low toxicity therapy, and opportunities for building strategic advantages. It also includes an analysis of the company's competitive advantage, business model, market forces, strengths, weaknesses and opportunities for further assessment.
1- MarketingBefore putting the product into the market, the prod.docx
1- Marketing
Before putting the product into the market, the product goes through several stages. One of the most important stages is to determine the price of the product. After that, it will be studied by asking questions to customers and anticipate their requirements in terms of shape, colour phrases recorded on it. It can be applied using servery or interview the customer. Finally, the product needs to be promoting before it is been released, so electronic, and visual and audio can be used as advertising. However, in this experiment, we will focus only on the total cost of the product and then work on finding who develops the product….[9] [10].
1.1 Estimating of the total price.
For the antibiotic spray, it can be estimate the total price depend on the type of the material which were be used. Thus, the material in the table estimates the total price.
Material
Discerption
Brand/ manufacture
Price Ink VAT.
[1] Cefuroxime(as Cefuroxime sodium) 1.5 gram.
CEFUROXIME is a cephalosporin antibiotic. It is used to treat certain kinds of bacterial infections. It will not work for colds, flu, or other viral infections
£4.70
[2] Sterile Water (1000ml)
Single Bottle of Sterile Water (1000ml)
Baxter
£3.54
[3] 73.5 mg of sodium
Sodium Bicarbonate 2kg - Pharmaceutical Grade (Bicarb/Bicarbonate of Soda)
£6.49
[1] Metronidazole
Metronidazole 500mg/100ml infusion 100ml bags (A A H Pharmaceuticals Ltd)
£63.86
[4] Phosphatebuffer (pKa=7.2)
PBS405.1 Virtual PHOSPHATE BUFFERED SALINE pH 7.4 10X Liquid Concentrate, 1L
£22.75
[5] Brilliant Blue FCF
1 kilogram
£6-8
[6] 100ml Stainless Steel
Empty stainless bottle spray
£7-9
Total price
£118
2- Companies and industry
There are many companies interested to work on or collaborate for developing the antibiotic. Following, there are some of the companies, Charities and universities, which they work hardly to improve public health and more specifically in the development of antibiotics. Thus, the product will be a focuses for them and new idea that can be started to develop and prove its effectiveness. Then, it can be put in the market, which many people can take advantage of the ease and licences of the product.
2.1. GSK Company [13]
At GSK, they are at the forefront of researching new ways to tackle some of the world’s biggest healthcare challenges. So as antibiotic resistance grows, they are investing in new ways to fight infection.
Their approach is to make the most of their own expertise and experience, while at the same time forming complementary partnerships and alliances with others who bring different kinds of expertise. Their vision for the world, where everyone has access to the vaccines they need, depends on a steady supply of great ideas and brilliant science. They have much to offer and through collaboration, they can achieve so much more.
For example, more than 90% of the vaccines in their pipeline are being developed in partnership with others. They have a long track rec.
The 10 Companies Booming in Healthcare Sector
Acknowledging the remarkable contribution of the leading companies in the care sector, we bring to you the special issue of “The 10 Companies Booming in Healthcare Sector”. This edition portrays the inspiring stories of the listed pre-eminent organizations that are shaping the future of healthcare through innovation and dedication.
Case for emerging 9 sustaining oncology innovation
The document discusses the challenges facing major oncology innovator companies as their traditional cash cow drugs lose market share to biosimilars. It argues that innovators need to look beyond traditional Western markets and consider partnering with emerging markets like India to strengthen their healthcare systems and generate sustainable revenues. This could help build new cash cows to fund future innovation while improving access in populations with high cancer rates. The document outlines how an integrated approach with partners across government, non-profits and hospitals could work to mutually benefit patients, innovators and healthcare systems in emerging markets.
Canada's 10 Most Valuable Healthcare Solution Providers July 2021
Canada's 10 Most Valuable Healthcare Solution Providers July 2021 features some exceptional Canadian healthcare solution providers
Health-Tech: Endless opportunities & endless disruption
This document provides an overview of the health tech industry and key trends. It discusses how the industry has adopted digital technologies across areas like drug manufacturing, clinical trials, hospitals, and care services. The COVID-19 pandemic further increased adoption rates. The document analyzes funding and deal size data from the past 5 years to identify fast growing segments like telemedicine, anti-counterfeiting tech, and the rise of tech giants in healthcare investing. Post-pandemic, virtual consultations are expected to become more mainstream. The future of healthcare is predicted to rely more on technologies like artificial intelligence, digital tools, and data analytics.
The 10 most innovative healthcare companies in 2020
Alertgy was founded by Marc Rippen after his wife had a near-fatal low blood sugar attack. Rippen saw the need for an automated glucose monitor and alert system for diabetics that was non-invasive, inexpensive, and easy to use. As the president and founder of Alertgy, Rippen has over 30 years of experience in engineering and has commercialized many groundbreaking technologies. Alertgy provides the first non-invasive wearable continuous glucose monitor and alert system that can measure true blood glucose levels and send alerts when levels are too high or too low. This solution aims to improve compliance for diabetics and reduce hospital admissions related to blood sugar issues.
Practical guide on private funding for EU eHealth SMEs
The document discusses trends in digital health and investment in Europe compared to the US. Some key points:
1) Venture funding for digital health has grown rapidly in recent years on both sides of the Atlantic, with over $4 billion invested in the US in 2014 alone. However, investment in Europe still lags behind, though some large funding rounds have occurred.
2) Most digital health startups in Europe are still at the seed stage, but more are qualifying for Series A funding and beyond in recent years.
3) Factors holding back more investment in Europe include digital health initiatives still being in early stages of development and a fragmented healthcare system compared to the larger US market. Interviews with an investor
Johnson & Johnson Pharmaceutical Business Review
The document is an agenda for an investor presentation. It outlines the schedule for the day which includes presentations on the company's enterprise overview, pharmaceutical commercial and R&D strategies, and various therapeutic areas. It also includes notices about forward-looking statements and new molecular entities being discussed. The speakers and locations are listed next to each topic.
R & D PPT.pptx
The document outlines India's national policy on R&D and innovation in pharmaceuticals and medical devices. It discusses opportunities in areas like generics, APIs, vaccines, and biosimilars. The policy aims to incentivize investments, create an enabling ecosystem for innovation through strengthening academic-industry linkages, building infrastructure, and streamlining regulatory processes.
Healthcare Industry Analysis for Investors
The document discusses the healthcare sector as an investment opportunity. It notes that healthcare demand is defensive as people will still need it even during economic downturns. It identifies top industry players as drug companies, biotech companies, and medical device companies. Drug companies and device firms tend to have strong competitive advantages or "wide economic moats" due to high costs of research and development, patent protection, and other barriers to entry. However, the sector also carries risks such as long development timelines for drugs, regulatory hurdles, and loss of revenue when patents expire. The document provides an overview of factors to consider when evaluating investment opportunities in healthcare companies.
10 Most Innovative CRO’s To Watch In 2022.pdf
During the COVID-19 pandemic, if clinicians, healthcare service-providing staff, nurses, and doctors were battling at the forefront, then the Clinical Research Organizations (CROs) have been working hard
Asia HealthTech Investments by Julien de Salaberry (30 June 2015)
Kickstart Ventures' 2nd HealthTech Forum featured Julien de Salaberry, a globally-recognised expert on healthcare and technology.
Julien, the Chief Innovation Officer and Founder of The Propell Group (based in Singapore), talked about healthcare trends in Southeast Asia and how “frugal innovation" can be done in healthcare delivery.
And yeah, if you've got an interesting healthtech startup, message us at info@kickstart.ph. #startupPH
Powering the Future of Healthcare in Asia | Propell | Media Exploits
Presentation given at AStar ETPL Media Exploits conference on why healthtech will power the future of healthcare in Asia
Similar to Investment Opportunities in Meditech (20)
10 Best Healthcare Companies in Australia & New Zealand 2023V3 1.pdf
10 Best Healthcare Companies in Australia & New Zealand 2023V3 1.pdf
10 Best Healthcare Companies in Australia & New Zealand 2023V3 1.pdf
10 Best Healthcare Companies in Australia & New Zealand 2023V3 1.pdf
Trailblazing The Immuno-Oncology Frontier Best Companies Of 2024.pdf
Trailblazing The Immuno-Oncology Frontier Best Companies Of 2024.pdf
10 of the Best Healthcare Brands in 2020 | Insights Care
10 of the Best Healthcare Brands in 2020 | Insights Care
1- MarketingBefore putting the product into the market, the prod.docx
1- MarketingBefore putting the product into the market, the prod.docx
Case for emerging 9 sustaining oncology innovation
Case for emerging 9 sustaining oncology innovation
Canada's 10 Most Valuable Healthcare Solution Providers July 2021
Canada's 10 Most Valuable Healthcare Solution Providers July 2021
Health-Tech: Endless opportunities & endless disruption
Health-Tech: Endless opportunities & endless disruption
The 10 most innovative healthcare companies in 2020
The 10 most innovative healthcare companies in 2020
Practical guide on private funding for EU eHealth SMEs
Practical guide on private funding for EU eHealth SMEs
Asia HealthTech Investments by Julien de Salaberry (30 June 2015)
Asia HealthTech Investments by Julien de Salaberry (30 June 2015)
Powering the Future of Healthcare in Asia | Propell | Media Exploits
Powering the Future of Healthcare in Asia | Propell | Media Exploits
More from Jon Bennion-Pedley
Green Bonds Investment Opportunities
The current green bond investment opportunities offered by Investment Owl offer a return of between 8.25% and 12% per annum which is paid quarterly and takes the form of fully listed and tradeable ‘A’ rated income bonds. A minimum investment of $50,000 is required. This type of green investment proposition is becoming increasingly popular.
Introduction to the Ugandan Football Academy
Investment Owl’s investment opportunity for Ugandan football aims to
Case Study: Football Academy in West Africa
The proposed business model for the new football academy in Uganda has already been tried and tested, with a successful venture in West Africa.
How Businesses Can Support Their Charity Partners
How a business supports a charity will vary depending on the desired outcome of the partnership.
Ethical Investment Industries
Investment Owl analyses a wealth of potential investments to discover the best opportunities for clients. Opportunities could include....
The Social Entrepreneur
While the potential to earn a profit is what motivates most entrepreneurs, there are those for whom this motive does not prevent them from making a positive impact in society. Social entrepreneurs pursue ideas that can solve issues faced by communities, and they are willing to take on the risk required to implement positive change.
The Benefits of Donating Your Time to a Charity
Volunteering time is free to do, and can be done in person or virtually
The State of the Global Impact Investing Market
This information is according to a 2020 impact investor survey conducted by the Global Impact Investing Network (GIIN).
Charitable Giving in the UK
This information is according to key findings from the Charities Aid Foundation UK Giving 2019 report:
Top Firms for Impact Investing
Triodos Investment Management currently has around $5 billion in assets under management and focuses on areas such as renewable energy, healthcare, sustainable agriculture, and education
Calculating the Value of Impact Investing
Impact investing involves the investor looking for additional benefits from an investment besides financial gain. It usually involves investing in something that benefits either society or the environment.
Investors can use a metric called the Impact Multiple of Money, or IMM, to calculate the value of impact investing.
Statistics for Female Education in Sub-Saharan Africa
This information is according to data shared by CAMFED
Statistics for High-Net-Worth Individual Investing in 2020
In the aftermath of the coronavirus pandemic, high-net-worth individual investors are looking for alternatives to boost their portfolios.
The Alternative Investments HNWIs are Considering After COVID-19
As the COVID-19 pandemic alters the economic landscape around the globe, many investors are altering their investment strategy to try and ride the wave. Alternative investments, once typically a small part of diversifying a portfolio, are now becoming one of the most popular asset classes for investment.
Defining Development Aid
Development aid is the term given to the financing provided to improve living conditions in impoverished nations and regions by public actors from countries that are more financially well off.
Charitable Giving Through the Generations
A 2018 report on philanthropy found that the younger generations are the most generous when it comes to charitable giving. Millennials donated a significant percentage of the total amount given to charities, according to a representative survey of 1,000 people.
Global Statistics for Female Education
These statistics are according to statistics shared by the United Nations entity UN Women
Key Investment Opportunities from Investment Owl
The quarterly income 10% investment opportunity from Investment Owl focuses on properties near the planned Crossrail 2 development, with potential returns of 10% per annum for investors.
Businesscard2 0
A multimedia business card for a multimedia age - communicate EVERYTHING you in less than 20 seconds from your mobile phone: social networks, video, photos, documents and weblinks.
No more crumpled traditional cards or expensive printing bills.
How did you operate without it?
More from Jon Bennion-Pedley (19)
Statistics for Female Education in Sub-Saharan Africa
Statistics for Female Education in Sub-Saharan Africa
Statistics for High-Net-Worth Individual Investing in 2020
Statistics for High-Net-Worth Individual Investing in 2020
The Alternative Investments HNWIs are Considering After COVID-19
The Alternative Investments HNWIs are Considering After COVID-19
Recently uploaded
Methanex Investor Presentation - April 2024
Methanex is the world's largest producer and supplier of methanol. We create value through our leadership in the global production, marketing and delivery of methanol to customers. View our latest Investor Presentation for more details.
Collective Mining | Corporate Presentation - June 2024
Collective Mining | Corporate Presentation - June 2024
Osisko Gold Royalties Ltd - Corporate Presentation, June 12, 2024
Osisko Gold Royalties Ltd - Corporate Presentation, June 12, 2024
Cleades robinson:The Diplomat is Blue
Cleades Robinson, a respected leader in Philadelphia's police force, is known for his diplomatic and tactful approach, fostering a strong community rapport.
快速办理(CUBoulder毕业证书)科罗拉多大学博尔德分校毕业证录取通知书一模一样
学校原件一模一样【微信：741003700 】《(CUBoulder毕业证书)科罗拉多大学博尔德分校毕业证》【微信：741003700 】学位证，留信认证（真实可查，永久存档）原件一模一样纸张工艺/offer、雅思、外壳等材料/诚信可靠,可直接看成品样本，帮您解决无法毕业带来的各种难题！外壳，原版制作，诚信可靠，可直接看成品样本。行业标杆！精益求精，诚心合作，真诚制作！多年品质 ,按需精细制作，24小时接单,全套进口原装设备。十五年致力于帮助留学生解决难题，包您满意。
本公司拥有海外各大学样板无数，能完美还原。
1:1完美还原海外各大学毕业材料上的工艺：水印，阴影底纹，钢印LOGO烫金烫银，LOGO烫金烫银复合重叠。文字图案浮雕、激光镭射、紫外荧光、温感、复印防伪等防伪工艺。材料咨询办理、认证咨询办理请加学历顾问Q/微741003700
【主营项目】
一.毕业证【q微741003700】成绩单、使馆认证、教育部认证、雅思托福成绩单、学生卡等！
二.真实使馆公证(即留学回国人员证明,不成功不收费)
三.真实教育部学历学位认证（教育部存档！教育部留服网站永久可查）
四.办理各国各大学文凭(一对一专业服务,可全程监控跟踪进度)
如果您处于以下几种情况：
◇在校期间，因各种原因未能顺利毕业……拿不到官方毕业证【q/微741003700】
◇面对父母的压力，希望尽快拿到；
◇不清楚认证流程以及材料该如何准备；
◇回国时间很长，忘记办理；
◇回国马上就要找工作，办给用人单位看；
◇企事业单位必须要求办理的
◇需要报考公务员、购买免税车、落转户口
◇申请留学生创业基金
留信网认证的作用:
1:该专业认证可证明留学生真实身份
2:同时对留学生所学专业登记给予评定
3:国家专业人才认证中心颁发入库证书
4:这个认证书并且可以归档倒地方
5:凡事获得留信网入网的信息将会逐步更新到个人身份内，将在公安局网内查询个人身份证信息后，同步读取人才网入库信息
6:个人职称评审加20分
7:个人信誉贷款加10分
8:在国家人才网主办的国家网络招聘大会中纳入资料，供国家高端企业选择人才
Collective Mining | Corporate Presentation - June 2024
Collective Mining | Corporate Presentation - June 2024
ppt-namibia-worldeconomy-standardbank.ppt
World economy charts case study presented by a Big 4
World economy charts case study presented by a Big 4
World economy charts case
World economy charts case study presented by a Big 4
World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4
World economy charts case study presented by a Big 4
World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4World economy charts case study presented by a Big 4study presented by a Big 4
ZKsync airdrop of 3.6 billion ZK tokens is scheduled by ZKsync for next week.pdf
The world of blockchain and decentralized technologies is about to witness a groundbreaking event. ZKsync, the pioneering Ethereum Layer 2 network, has announced the highly anticipated airdrop of its native token, ZK. This move marks a significant milestone in the protocol's journey, empowering the community to take the reins and shape the future of this revolutionary ecosystem.
Understanding-the-E-Way-Bill-A-Digital-Transformation-in-Logistics.pptx
The E-Way Bill revolutionizes logistics by digitizing the documentation of goods transport, ensuring transparency, tax compliance, and streamlined processes. This mandatory, electronic system reduces delays, enhances accountability, and combats tax evasion, benefiting businesses and authorities alike. Embrace the E-Way Bill for efficient, reliable transportation operations.
UnityNet World Environment Day Abraham Project 2024 Press Release
June 12, 2024 UnityNet International (#UNI) World Environment Day Abraham Project 2024 Press Release from Markham / Mississauga, Ontario in the, Greater Tkaronto Bioregion, Canada in the North American Great Lakes Watersheds of North America (Turtle Island).
Recently uploaded (14)
Collective Mining | Corporate Presentation - June 2024
Collective Mining | Corporate Presentation - June 2024
Osisko Gold Royalties Ltd - Corporate Presentation, June 12, 2024
Osisko Gold Royalties Ltd - Corporate Presentation, June 12, 2024
Collective Mining | Corporate Presentation - June 2024
Collective Mining | Corporate Presentation - June 2024
Mandalay Resouces June 2024 Investor Relations PPT
Mandalay Resouces June 2024 Investor Relations PPT
ZKsync airdrop of 3.6 billion ZK tokens is scheduled by ZKsync for next week.pdf
ZKsync airdrop of 3.6 billion ZK tokens is scheduled by ZKsync for next week.pdf
Understanding-the-E-Way-Bill-A-Digital-Transformation-in-Logistics.pptx
Understanding-the-E-Way-Bill-A-Digital-Transformation-in-Logistics.pptx
UnityNet World Environment Day Abraham Project 2024 Press Release
UnityNet World Environment Day Abraham Project 2024 Press Release
Investment Opportunities in Meditech
- 1. Investment Opportunities in Meditech Jonathan Bennion-Pedley Investment
- 2. Page 2 | Jonathan Bennion-Pedley Investment Opportunities in Meditech In the wake of the pandemic, medical innovations are causing more excitement than ever before. Not only do these innovations improve lives, but the enterprises behind them are likely to be extremely profitable too. Investment Owl is helping to raise funds for these concerns.
- 3. Jonathan Bennion-Pedley I Page 3 “ Investment Owl does not provide advice or investment products directly to investors in Uganda; the company makes opportunities available to Ugandan investors through a team of local CMA regulated partners. Types of Innovation Some of the meditech businesses that Investment Owl has partnered with have innovated, for exam- ple: a way to administer vaccines without the use of needles; a virtual monitoring and treatment platform to assist those suffering from dementia; a diagnostic platform and test that significantly in- creases the success rate of chemotherapy; and a drug that improves the survival rate of those with pancreatic cancer. Opportunities for Investment Investment Owl offers a multitude of opportunities for its clients to become shareholders in the med- itech enterprises that it partners with. All the tech- nology that is used by these companies is patented and each is generating substantial interest from major pharmaceutical and healthcare companies; the shar
- 4. For more information about this topic, visit the blog of Jonathan Bennion-Pedley. Jonathan Bennion-Pedley